Richard Macaulay, PhD

Richard Macaulay, PhD

Richard Macaulay, PhD

Senior Director, Pricing & Market Access

Richard is Senior Director with over 7 years’ experience at PAREXEL. He has expertise in a range of pricing and market access projects, including value message development, quantitative and qualitative pricing research, payer evidence planning, primary and secondary research, and market access strategy across a range of disease areas.

Work experience

Richard’s experience includes leading a commercialization partnership with a company developing an oncology drug across various indications. This collaborative engagement which spanned over five years included development of HTA and pricing landscape assessments, global value dossiers, objection handling, primary payer and KOL research, competitive analysis, and strategic input and analysis on the pricing, positioning and strategic evidence generation plans.

Richard is a recognized thought leader with a particular interest in how oncology drugs can receive regulatory approval and payer reimbursement in Europe and the US based on clinical trial packages lacking Phase III data. This is reflected in having over 40 research pieces to his name including posters, conference presentations, webinars, and manuscripts.


Richard has completed a PhD from University College London in how CTLA-4 and PD-1 mediate age-related immune declines, and is a graduate of Cambridge University where he received a BA (Hons) in Medicine.

We are always available for a conversation.